Director - Clinical Design Physician – Cardiometabolic Health
Company: Eli Lilly and Company
Location: Indianapolis
Posted on: February 2, 2026
|
|
|
Job Description:
At Lilly, we unite caring with discovery to make life better for
people around the world. We are a global healthcare leader
headquartered in Indianapolis, Indiana. Our employees around the
world work to discover and bring life-changing medicines to those
who need them, improve the understanding and management of disease,
and give back to our communities through philanthropy and
volunteerism. We give our best effort to our work, and we put
people first. We’re looking for people who are determined to make
life better for people around the world. Organization Overview: At
Lilly, we serve an extraordinary purpose. We make a difference for
people around the globe by discovering, developing and delivering
medicines that help them live longer, healthier, more active lives.
Not only do we deliver breakthrough medications, but you also can
count on us to develop creative solutions to support communities
through philanthropy and volunteerism. Purpose: The Clinical Design
function was created to establish study design as a core
capability, with tightly integrated cross-functional experts
providing innovative, high quality study designs that transition
seamlessly to execution. The purpose of the Director - Clinical
Design Physician – Cardiometabolic Health role is to provide
Medical leadership within the group. The Physician must have deep
understanding of the biopharmaceutical industry, drug development,
Diabetes-associated comorbidities, clinical research, and clinical
study design. Through application of Industry training, clinical
expertise, and relevant experience, the Director - Clinical Design
Physician – Cardiometabolic Health plays a key role in the
development of program and trial design options and translation
into high quality clinical trial protocols. While Clinical Design’s
main focus is on proof of concept and registration clinical
studies, the role may work on trials across early and/or late
phases of development and commercialization of the product. The
Clinical Design Physician may participate in the authoring and/or
review process for publications and as needed works with regulatory
and other governmental agencies. They will participate, at times,
in activities largely led by Asset Teams, such as outreach medical
activities aimed at the external clinical customer community,
including thought leaders; the development and implementation of
the business unit and global strategy for the product; and various
medical activities in support of demand realization. Primary
Responsibilities The primary responsibilities of the Director -
Clinical Design Physician – Cardiometabolic Health are generally
related to phase II (proof of concept) to III (registration)
studies in patients with commonly occurring cardiometabolic disease
states (e.g. obesity, cardiovascular disease, renal and hepatic
complications, and women's health comorbidities). The core job
responsibilities typically include those listed below as well as
all other duties as assigned. Clinical Plan Options and Clinical
Trial Protocols As the Medical leader on a cross-functional
Clinical Design team, translate therapeutic area and asset team
strategy into clear objectives and associated clinical development
program and trial optionality. Optionality will address business
and customer needs (patient, prescriber, payer, and/or regulator);
be in alignment with phase of product lifecycle; and clearly
articulate associated tradeoffs in value (information gathered,
risks created/discharged, cost, and time). Represent program and
trial design optionality to asset teams and Sr. Leaders to inform
prioritization of an option that will be translated into a clinical
protocol(s). Adjust optionality in accordance with feedback from
leadership. Develop study protocols in collaboration with the
Design Team and partners in the Lilly Cardiometabolic Health
Business Unit Development Team, Discovery, Program Phase Medicine,
and Clinical Pharmacology. Provide insight into impact of
study/protocol design features to execution speed/efficiency.
Contribute to the development of asset strategy (e.g.
identification of target patient population) in partnership with
the asset team. Contribute to business unit and global alignment of
portfolio clinical strategy and the associated asset-specific
clinical plans. Clinical Research/Trial Packages, Execution and
Support Collaborate with clinical research staff in the design and
conduct clinical trials (e.g. sample size, patient commitment,
timelines, grants, and governance review interactions). Champion
key strategic initiatives, such as decentralized clinical trials
and diversity/equity/inclusion in clinical research. Understand how
design elements influence the ability to deliver on these
initiatives and influence adoption of designs that enable their
success. Review risk profiles to ensure appropriate communication
of risk to study subjects. Participate in investigator
identification and selection, in conjunction with Clinical Design
and clinical teams. Actively participate in subject recruitment,
diversity, and retention efforts. Support seamless transition of
protocols from design to execution. Scientific Data
Dissemination/Exchange Knowledge of and compliance with local laws
and regulations, and global policies and procedures, compliance
guidelines with respect to data dissemination and interactions with
external health care professionals. Establish and maintain
appropriate collaborations and relationships with external experts,
thought leaders, and the general medical community on an
international basis. Develop and maintain appropriate
collaborations and relationships with relevant professional
societies. Participate in development of scientific data
dissemination, and preparation of final reports and publications.
Scientific / Technical Expertise Critically read and evaluate the
relevant medical literature; know the status and data from
competitive products; and keep updated with medical and other
scientific developments relevant to the product. Be aware of
current trends and projections for clinical research, and practice,
and access in the therapeutic area(s) relevant to the product.
Engage appropriately with the asset teams on relevant external
activities to have good understanding of their patients, medical
and payer communities, and business strategy. Shared Learning Focus
on organizational learning to identify best practices, delivering
these as systemized standard approaches with ultimate goal to make
program and protocol design streamlined, less burdensome, faster,
and less expensive. Closely collaborate with asset teams and
execution teams to understand the impact of design on speed to
protocol approval and study startup. Work over time with other
Clinical Design staff to analyze experience and improve approaches.
Work closely with counterparts in Clinical Design and therapeutic
areas to continue to evolve Lilly standards, tools, and best
practices that span drug development. Provide clinical leadership
in collaboration with other Clinical Design members in appropriate
development of standardized/simplified processes, templates, and
tools. Minimum Requirements: Medical Doctor or Doctor of
Osteopathy. Must be board eligible or certified in appropriate
specialty/subspecialty or have completed the comparable level of
post-medical school clinical training relevant to the country of
hiring. U.S. trained physicians must have achieved board
eligibility or certification. Foreign medical graduates in U.S.
based jobs, who are not U.S. board eligible or certified may be
hired directly for employment in the U.S. at the discretion of the
Chief Medical Officer. Non-U.S. trained physicians must have
completed education and training at a medical school that meets the
requirements of the Liaison Committee on Medical Education (LCME).
For the recognized list of foreign medical schools and the
disapproved list, see http://www.in.gov/pla/2799.htm Pharmaceutical
Industry experience in of at least three years and adequate to
provide strong grounding in the drug development progress, clinical
trial principles, and scientific decision-making. Experience of a
minimum of 3 years in multiple areas relevant to clinical trial
design (e.g., statistical/inferential methods, rating instruments,
regulatory standards, safety assessment, investigator/site
management, decentralized clinical trials). Additional Preferences:
Clinical trial design leadership in at least one key in scope
development phase (proof of concept, dose ranging, registration,
and/or phase 3b/4 studies). Board certification or eligibility
within a specialty directly relevant to comorbidities of Diabetes
(e.g. cardiology, obesity medicine, nephrology, hepatology)
strongly preferred Clinical research experience in one or more
comorbidities of Diabetes. Strong understanding of relevant
comorbidities of Diabetes – pathology, pathophysiology, unmet
needs, and treatment standards. Strong interpersonal,
organizational, and negotiation skills. Ability to influence others
(both cross-functionally and within the function) to advance
business strategies and objectives. Excellent teamwork skills.
Fluent in English, with strong communication skills, verbal and
written. Drug development experience spanning all core relevant
phases (proof of concept through registration). Understanding of
how design elements translate into delivery. Bias for simplifying,
reducing burden, and creation of value through excellent design.
Strong communication skills demonstrated in a variety of modalities
(e.g. presentations, meetings, creation of protocols and regulatory
documents) and with broad set of stakeholders (e.g. team leaders,
Sr. Leader decision makers, medical and non-medical counterparts,
thought leaders, investigators, regulators). Bias for action.
Desire to influence a broad portfolio across phases through
exceptional clinical plan optionality and study design. MBA or
similarly relevant training in the business of life sciences.
Strong foundation in statistical science, including Bayesian
statistics, as applied to study design (e.g. sample size
determination, setting of critical success factors). Ability to
communicate effectively with statisticians and help translate
complex principles to inform design optionality and protocols.
Willing to relocate to Indianapolis. If unable to relocate,
demonstrated ability to work with high effectiveness from a remote
location in a hybrid environment. Willing to travel for business
critical events, teambuilding, and to develop a strong internal
network. Willing to engage in limited domestic and international
travel to the degree appropriate to support the business of the
team. OTHER INFORMATION Primary internal interactions Clinical
Design teammates and leadership Clinical planning, operations,
CRPs/Ss, other research staff Team leaders and COOs Sr. Leaders
within Clinical, R&D, therapeutic areas, and business units
Statisticians Scientific communication associates Health outcomes
research consultants/research scientists Regulatory directors,
scientists, and associates Product directors, managers, and
associates of the brand teams Legal counsel Therapeutic area
physicians, development CRP/Ss, medical affairs CRP/Ss, early phase
physicians, and Sr. Medical leaders Global Marketing director or
manager Corporate patient safety External Contacts Scientific and
clinical experts, thought leaders Lilly clinical investigators
Practicing physicians/prescribers Regulatory agency personnel
Professional association staff and leaders Disease advocates and
lay organizations focused on relevant health issues Formulary
representatives (private and government) Lilly is dedicated to
helping individuals with disabilities to actively engage in the
workforce, ensuring equal opportunities when vying for positions.
If you require accommodation to submit a resume for a position at
Lilly, please complete the accommodation request form (
https://careers.lilly.com/us/en/workplace-accommodation ) for
further assistance. Please note this is for individuals to request
an accommodation as part of the application process and any other
correspondence will not receive a response. Lilly is proud to be an
EEO Employer and does not discriminate on the basis of age, race,
color, religion, gender identity, sex, gender expression, sexual
orientation, genetic information, ancestry, national origin,
protected veteran status, disability, or any other legally
protected status. Our employee resource groups (ERGs) offer strong
support networks for their members and are open to all employees.
Our current groups include: Africa, Middle East, Central Asia
Network, Black Employees at Lilly, Chinese Culture Network,
Japanese International Leadership Network (JILN), Lilly India
Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ
Allies), Veterans Leadership Network (VLN), Women’s Initiative for
Leading at Lilly (WILL), enAble (for people with disabilities).
Learn more about all of our groups. Actual compensation will depend
on a candidate’s education, experience, skills, and geographic
location. The anticipated wage for this position is $198,000 -
$356,400 Full-time equivalent employees also will be eligible for a
company bonus (depending, in part, on company and individual
performance). In addition, Lilly offers a comprehensive benefit
program to eligible employees, including eligibility to participate
in a company-sponsored 401(k); pension; vacation benefits;
eligibility for medical, dental, vision and prescription drug
benefits; flexible benefits (e.g., healthcare and/or dependent day
care flexible spending accounts); life insurance and death
benefits; certain time off and leave of absence benefits; and
well-being benefits (e.g., employee assistance program, fitness
benefits, and employee clubs and activities).Lilly reserves the
right to amend, modify, or terminate its compensation and benefit
programs in its sole discretion and Lilly’s compensation practices
and guidelines will apply regarding the details of any promotion or
transfer of Lilly employees. WeAreLilly
Keywords: Eli Lilly and Company, Kokomo , Director - Clinical Design Physician – Cardiometabolic Health, Science, Research & Development , Indianapolis, Indiana